(Z )-2-(2-AMINOTHIAZOL-4-YL)-2-(HYDROXYIMINO)-N -((3RS ,5AR ,6R )-3-METHYL-1,7-DIOXO-1,3,4,5A,6,7-HEXAHYDROAZETO(2,1-B )FURO(3,4-D )(1,3)THIAZIN-6-YL(ACETAMIDE
Chemical
FDA Substance Registry (openFDA)
Chemical Identification
| INCI Name | (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-hydroxyimino-N-[(4R,5R)-9-methyl-3,11-dioxo-10-oxa-6-thia-2-azatricyclo[6.3.0.02,5]undec-1(8)-en-4-yl]acetamide |
|---|---|
| PubChem CID | 87815632 |
| Molecular Formula | C14H13N5O5S2 |
| InChIKey | InChI=1S/C14H13N5O5S2/c1-4- |
| SMILES | CC1C2=C(C(=O)O1)N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\O)/C4=CSC(=N4)N)SC2 |
Known Aliases (2)
Common Name
CEFDINIR IMPURITY E
CEFDINIR LACTONE
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | 0W2W754Q55 |
(Z )-2-(2-AMINOTHIAZOL-4-YL)-2-(HYDROXYIMINO)-N -((3RS ,5AR ,6R )-3-METHYL-1,7-DIOXO-1,3,4,5A,6,7-HEXAHYDROAZETO(2,1-B )FURO(3,4-D )(1,3)THIAZIN-6-YL(ACETAMIDE |
PUBCHEM: 87815632 FDA UNII: 0W2W754Q55 |
Record Info
| ID | B5KJ6oZ7WHXBXAsi5HRa3u |
|---|---|
| Created | April 10, 2026, 8:47 p.m. |
| Modified | April 10, 2026, 8:47 p.m. |
| Enriched | April 11, 2026, 12:09 a.m. |
| Data Source | FDA Substance Registry (openFDA) |